Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
Search
Advanced Search
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Yan Ling Ong"

Keywords

"Yan Ling Ong"

Reply to Correspondence

SHOULD DIRECT-ACTING ANTIVIRAL BE CONSIDERED FOR ALL PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA?
Yan Ling ONG, Apichat KAEWDECH, Yu Jun WONG
Received March 5, 2025  Accepted March 10, 2025  Published online March 13, 2025  
DOI: https://doi.org/10.3350/cmh.2025.0257    [Accepted]
  • 1,438 View
  • 19 Download
Editorial
Editorial on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
Yan Ling Ong, Apichat Kaewdech, Daniel Q Huang, Yu Jun Wong
Received February 14, 2025  Accepted February 21, 2025  Published online February 24, 2025  
DOI: https://doi.org/10.3350/cmh.2025.0174    [Epub ahead of print]

Citations

Citations to this article as recorded by  Crossref logo
  • Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage
    Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu
    Clinical and Molecular Hepatology.2025;[Epub]     CrossRef
  • 3,538 View
  • 42 Download
  • Crossref
First First Prev Prev
Page of 1
Next Next Last Last
CMH : Clinical and Molecular Hepatology
Twitter